Current Opinion in Urology

Papers
(The TQCC of Current Opinion in Urology is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Editorial introductions76
Endemic statistical paradoxes in epidemiologic studies distort knowledge on prostate cancer: mitigation and caution of fallacies in prostate cancer causal epidemiological studies53
Immunotherapy combinations for metastatic castration-resistant prostate cancer – failed trials and future aspects51
Research frontiers in urology51
Tumor-informed circulating tumor DNA in urothelial carcinoma: a promising novel biomarker28
Prognostic impact of serum testosterone in metastatic hormone-naive prostate cancer: a systematic review and meta-analysis27
Minimizing overtreatment and maximizing oncologic outcomes in upper tract urothelial carcinoma24
Device-assisted intravesical chemotherapy treatment for nonmuscle invasive bladder cancer: 2022 update24
Paradigm shifts in fluid management using suction irrigation pressure autoregulating systems in modern flexible ureteroscopy with flexible and navigable suction access sheath: an evidence-based narrat21
Lithotripsy devices for percutaneous nephrolithotomy (PNL) – new developments21
Exploring the impact of artificial intelligence–enabled decision aids in improving patient inclusivity, empowerment, and education in urology: a systematic review by EAU endourology20
The role of innovations in advancing urologic oncologic patient care19
Molecular biomarkers to help select neoadjuvant systemic therapy for urothelial carcinoma of the bladder17
Tissue-based gene expression testing in localized prostate cancer17
Editorial introductions16
Editorial introductions15
RNA-based urinary assays for non-muscle invasive bladder cancer15
Testicular cancer with small metastatic burden: optimal approach in 202415
Systemic immunotherapy for BCG unresponsive nonmuscle-invasive bladder cancer14
Gold standard nephroureterectomy, chemoprophylaxis and surveillance in upper tract urothelial carcinoma14
Sustainable practices in hospital and operating theaters14
Applications used to minimize forgotten stents: a systematic review of the literature. Is it the dawn of a new era?13
Upper tract urothelial carcinoma: epidemiology, presentation, and high-risk endemic populations13
Risk of dementia associated with the use of anticholinergic medications: a review of recent literature12
The role of structural racism in shaping urologic outcomes12
Optimizing clinical risk stratification of localized prostate cancer12
Should endoscopic laser excision be offered as the first-line management for patients with eroded mesh? Outcomes of a systematic review of literature12
Personalised medicine in urothelial carcinoma: where do we stand and what is the way to go?11
Perioperative systemic therapy, current paradigm and ongoing clinical trials in upper tract urothelial cancer11
Sexually transmitted infections and the vaginal microbiome after vaginoplasty11
Lutetium-177-prostate-specific membrane antigen therapy for prostate cancer: current status and future prospects11
Oncolytic virus therapy for nonmuscle-invasive bladder cancer: current status and future directions11
Role of cytoreductive radical prostatectomy in men with oligometastatic prostate cancer on molecular imaging10
Is there a role for metastasis-directed therapy in bladder cancer?10
Does radical cystectomy still have a role in BCG-unresponsive nonmuscle invasive bladder cancer?10
Update on classification of oncocytic neoplasms of the kidney10
All about pulsed thulium:YAG laser: a systematic review from YAU Endourology and EAU Endourology10
Metabolic syndrome, obesity and cancer risk10
Perioperative platform for muscle-invasive bladder cancer trials: designs and endpoints10
Guiding treatment decisions in renal cell carcinoma: the role of biomarkers and clinical factors10
Endourology at the crossroads of innovation: technology, artificial intelligence and patient-focused care – an EAU endourology perspective10
Brief update of the new WHO classification for urothelial carcinoma9
Histologic subtypes of urothelial carcinoma: an update9
Preoperative geriatric assessment of urological patients: a narrative review9
Advances in laser pulse modulations9
Utility of augmented reality in endoscopic surgery for stones: European Association of Urology endourology up-to-date review9
Genetics of neuroendocrine prostate cancer: recent progress in genetic understanding is translating into therapeutic opportunities9
The role of radiotherapy in pelvic nodal recurrence following definitive treatment for prostate cancer9
Sex cord stromal tumors and tumors of the paratestis: new and old entities in a landscape of rare tumors8
Management of vaginoplasty canal complications8
Decoding germ cell tumours for clinicians8
Patient-reported outcomes in genital gender-affirming surgery8
The role of surgery for locally advanced urothelial cancers8
Liquid biomarkers in prostate cancer: recent advancements and future directions7
Preoperative patient optimization for endourological procedures: the current best clinical practice7
Retrograde intra renal surgery and safety: pressure and temperature. A systematic review7
Editorial introductions7
Upper tract urothelial carcinoma: conservative management - intraluminal adjuvant therapy, and surveillance7
Sarcomatoid urothelial carcinoma: advances and challenges7
Toxicities of taxane-based chemotherapy in prostate cancer7
Latest insights into the pathophysiology of bladder pain syndrome/interstitial cystitis7
MR-guided radiotherapy for prostate cancer: an inevitable transition?7
Extent of lymph node dissection and impact on survival in radical cystectomy for advanced bladder cancer7
Comparison of surgical effectiveness: kidney sparing surgery for upper tract urothelial carcinoma7
Treatment of adrenocortical carcinoma: oncological and endocrine outcomes7
Use of genomic markers to improve epidemiologic and clinical research in urology6
Medical therapy for male infertility6
Toxicities of novel androgen receptor pathway inhibitor targeted therapies in advanced prostate cancer6
Metastasis-directed therapy in oligometastatic and oligoprogressive renal cell carcinoma6
Percutaneous management of caliceal diverticula: a narrative review6
Inflammation and kidney stones: cause and effect?6
Digital health innovations in urology: telemedicine, wearables, and mobile applications – a systematic review of literature6
Lasers for benign prostatic hyperplasia (hybrid, blue diode, TFL, Moses). Which one to choose?6
Open versus robot-assisted surgery in reconstructive urology: lessons from vesicourethral anastomotic stenosis and radical cystectomy6
The carbon footprint of modern imaging6
Next-gen minimally invasive surgical therapies for benign prostatic hyperplasia: innovations, selection, and best practices- a review from European Association of Urology endourology6
Toxicities of radioligand and radioisotope therapy in prostate cancer: a systematic review and meta-analysis6
Surgical management of testicular cancer with limited retroperitoneal disease6
Bladder-sparing strategies in patients with clinically localized muscle-invasive bladder cancer6
AI-powered radiomics: revolutionizing detection of urologic malignancies6
Advanced sperm tests and impact on clinical male factor management6
Female urethral stricture disease: advances in diagnosis, surgical management, and standardized outcome reporting6
Association and risk of metabolic syndrome and kidney stone disease: outcomes from a systematic review and meta-analysis6
Ultra-hypofractionation for the treatment of macroscopic prostate bed recurrence: a focus on stereotactic radiotherapy and brachytherapy6
Novel intravesical delivery systems for nonmuscle invasive bladder cancer5
Does surgical removal of kidney stones help prevent the recurrence of urinary tract infections? A systematic review5
Overlooked and underserved: how healthcare fails men in the pursuit of equity5
Cost-effectiveness of serum, urine, and tissue-based prostate cancer biomarkers5
Role of cytoreductive surgery in the era of immunotherapy5
Definitions and unmet needs in the management of oligomestatic renal cell carcinoma in the modern era5
Detection of urological cancers by the signature of organic volatile compounds in urine, from dogs to electronic noses5
The role of surgical resection of the primary tumor in metastatic upper tract urothelial carcinoma: a systematic review and meta-analysis5
Lichen sclerosus associated urethral disease: reconstructive strategy and medical adjuncts5
New technologies for nephron-sparing surgery in upper urinary tract cancers5
Graft and flap choices in anterior urethroplasty: oral mucosa and beyond5
The final frontier: recent advances in distal urethral strictures reconstruction5
Metabolic evaluation: is there really a future?5
Prevention, diagnosis, and treatment of urolithiasis in geriatric patients - differences, similarities and caveats in comparison to the general population5
Integration of novel artificial intelligence tools in pediatric urologic practice5
Editorial: Future of kidney stone management5
The urothelial barrier in interstitial cystitis/bladder pain syndrome: its form and function, an overview of preclinical models5
Organ storage in renal transplantation5
What’s in a name? Why differentiation between biochemical recurrence and metastatic prostate cancer matters5
Genetics of testicular cancer: a review5
Preclinical models for bladder cancer therapy research5
The environmental impacts of anesthesia5
The use of MRI in urothelial carcinoma5
Editorial introductions5
0.34377384185791